BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 28031480)

  • 1. CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia.
    Riether C; Schürch CM; Bührer ED; Hinterbrandner M; Huguenin AL; Hoepner S; Zlobec I; Pabst T; Radpour R; Ochsenbein AF
    J Exp Med; 2017 Feb; 214(2):359-380. PubMed ID: 28031480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression.
    Schürch C; Riether C; Matter MS; Tzankov A; Ochsenbein AF
    J Clin Invest; 2012 Feb; 122(2):624-38. PubMed ID: 22232214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD70/CD27 pathway is critical for stimulation of an effective cytotoxic T cell response against B cell precursor acute lymphoblastic leukemia.
    Glouchkova L; Ackermann B; Zibert A; Meisel R; Siepermann M; Janka-Schaub GE; Goebel U; Troeger A; Dilloo D
    J Immunol; 2009 Jan; 182(1):718-25. PubMed ID: 19109206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents.
    Riether C; Pabst T; Höpner S; Bacher U; Hinterbrandner M; Banz Y; Müller R; Manz MG; Gharib WH; Francisco D; Bruggmann R; van Rompaey L; Moshir M; Delahaye T; Gandini D; Erzeel E; Hultberg A; Fung S; de Haard H; Leupin N; Ochsenbein AF
    Nat Med; 2020 Sep; 26(9):1459-1467. PubMed ID: 32601337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking CD27-CD70 costimulatory pathway suppresses experimental colitis.
    Manocha M; Rietdijk S; Laouar A; Liao G; Bhan A; Borst J; Terhorst C; Manjunath N
    J Immunol; 2009 Jul; 183(1):270-6. PubMed ID: 19525396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection.
    Izawa K; Martin E; Soudais C; Bruneau J; Boutboul D; Rodriguez R; Lenoir C; Hislop AD; Besson C; Touzot F; Picard C; Callebaut I; de Villartay JP; Moshous D; Fischer A; Latour S
    J Exp Med; 2017 Jan; 214(1):73-89. PubMed ID: 28011863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.
    Al Sayed MF; Ruckstuhl CA; Hilmenyuk T; Claus C; Bourquin JP; Bornhauser BC; Radpour R; Riether C; Ochsenbein AF
    Blood; 2017 Jul; 130(3):297-309. PubMed ID: 28495792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CD27-CD70 signaling in myocardial infarction and cardiac remodeling.
    Li W; Zhang F; Ju C; Lv S; Huang K
    Int J Cardiol; 2019 Mar; 278():210-216. PubMed ID: 30527529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of CD70-specific CAR T cells targeting acute myeloid leukemia.
    Wu G; Guo S; Luo Q; Wang X; Deng W; Ouyang G; Pu JJ; Lei W; Qian W
    Front Immunol; 2023; 14():1093750. PubMed ID: 36845088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of costimulatory CD27/CD70 pathway promotes corneal allograft survival.
    Narimatsu A; Hattori T; Usui Y; Ueno H; Funaki T; Komatsu H; Nakagawa H; Akiba H; Goto H
    Exp Eye Res; 2020 Oct; 199():108190. PubMed ID: 32798537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation response of leukemic cells to CD70 ligation oscillates with recurrent remission and relapse in a low-grade lymphoma.
    Kaufmann Y; Amariglio N; Rosenthal E; Hirsch YJ; Many A; Rechavi G
    J Immunol; 2005 Nov; 175(10):6940-7. PubMed ID: 16272354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction.
    Agematsu K; Nagumo H; Oguchi Y; Nakazawa T; Fukushima K; Yasui K; Ito S; Kobata T; Morimoto C; Komiyama A
    Blood; 1998 Jan; 91(1):173-80. PubMed ID: 9414282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells.
    Ranheim EA; Cantwell MJ; Kipps TJ
    Blood; 1995 Jun; 85(12):3556-65. PubMed ID: 7540066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD27-CD70 interactions regulate B-cell activation by T cells.
    Kobata T; Jacquot S; Kozlowski S; Agematsu K; Schlossman SF; Morimoto C
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11249-53. PubMed ID: 7479974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic CD70-driven costimulation impairs IgG responses by instructing T cells to inhibit germinal center B cell formation through FasL-Fas interactions.
    Beishuizen CR; Kragten NA; Boon L; Nolte MA; van Lier RA; van Gisbergen KP
    J Immunol; 2009 Nov; 183(10):6442-51. PubMed ID: 19864607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression and reverse signalling of CD70 on malignant B cells.
    Lens SM; Drillenburg P; den Drijver BF; van Schijndel G; Pals ST; van Lier RA; van Oers MH
    Br J Haematol; 1999 Aug; 106(2):491-503. PubMed ID: 10460611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural delineation and phase-dependent activation of the costimulatory CD27:CD70 complex.
    Liu W; Maben Z; Wang C; Lindquist KC; Li M; Rayannavar V; Lopez Armenta I; Nager A; Pascua E; Dominik PK; Oyen D; Wang H; Roach RC; Allan CM; Mosyak L; Chaparro-Riggers J
    J Biol Chem; 2021 Oct; 297(4):101102. PubMed ID: 34419446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.
    Ho AW; Hatjiharissi E; Ciccarelli BT; Branagan AR; Hunter ZR; Leleu X; Tournilhac O; Xu L; O'Connor K; Manning RJ; Santos DD; Chemaly M; Patterson CJ; Soumerai JD; Munshi NC; McEarchern JA; Law CL; Grewal IS; Treon SP
    Blood; 2008 Dec; 112(12):4683-9. PubMed ID: 18216294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity.
    Sauer T; Parikh K; Sharma S; Omer B; Sedloev D; Chen Q; Angenendt L; Schliemann C; Schmitt M; Müller-Tidow C; Gottschalk S; Rooney CM
    Blood; 2021 Jul; 138(4):318-330. PubMed ID: 34323938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy.
    Huang J; Kerstann KW; Ahmadzadeh M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
    J Immunol; 2006 Jun; 176(12):7726-35. PubMed ID: 16751420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.